RSS-Feed abonnieren

DOI: 10.1055/s-0045-1807257
The Pathological Complexity of Stroke and Rational Treatment Principles of Chinese Herbal Medicine

Abstract
This paper first analyzes the complexity of pathological processes involved in acute hemorrhagic or ischemic stroke, including primary and secondary brain injury manifestations and mechanisms, potential transformations between hemorrhage and infarction, and the impact of postbrain injury inflammation on disease progression. Based on decades of extensive clinical and pharmacological research on the usage of Chinese herbal medicine (CHM) monomers or formulas that promote blood circulation and remove blood stasis (such as Angong Niuhuang Wan, Buyang Huanwu Tang, Dahuoluo Wan, and Dushen Tang) for stroke treatment, it proposes that tonifying qi, promoting blood circulation, removing blood stasis, and detoxifying are rational treatment principles of CHM. These principles correspond to the following Western medical implications: tonifying qi corresponds to neuroprotection effects, promoting blood circulation corresponds to anticoagulation and thrombolysis, removing blood stasis addresses hematoma absorption and cerebral edema reduction, and detoxifying corresponds to anti-inflammatory actions. This paper further proposes from a systems medicine perspective that acute stroke is a complex disease requiring individualized CHM treatment with timely modifications rather than a one-size-fits-all approach. CHM monomers or formulas for promoting blood circulation and removing blood stasis, which have various effects such as lowering blood pressure, hemostasis, anticoagulation, antiplatelet, anti-inflammatory, promoting fibrinolysis, and edema reduction, must align with disease progression and be applied within appropriate therapeutic time windows to ensure efficacy and safety. Finally, this paper suggests that a combined use of acupuncture and CHM can potentially synergistically leverage their respective therapeutic strengths. Additionally, acupuncture shows clear benefits in the acute phase of intracerebral hemorrhage (ICH), such as stimulating the vagus nerve to enhance cerebral blood flow, reducing inflammation, as well as triggering hemostatic effects. By applying these rational treatment principles in an integrated approach, better CHM treatment outcomes and higher efficacy of stroke management may be attained.
Keywords
stroke - chinese herbal medicine - tonifying qi - promoting blood circulation - removing blood stasis - detoxifying - anti-inflammatory - therapeutic time windows - treatment with timely modificationCRediT Authorship Contribution Statement
Guanyuan Jin: Conceptualization, software and methodology, formal analysis, data curation, supervision, investigation, writing—original draft, review, and editing. Louis Lei Jin: Data curation, software and methodology, visualization, supervision, investigation, writing—review and editing. Belinda Jie He: Writing—review and editing.
Publikationsverlauf
Eingereicht: 02. November 2024
Angenommen: 28. Dezember 2024
Artikel online veröffentlicht:
08. April 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Ai L, Bi QQ, Wang Y. et al. Research progress on the antithrombotic effects and mechanisms of Buyang Huanwu Decoction. MTCMM-WST 2024; 26 (08) 2036-2045
- 2 Liu HL. Treatment of 54 cases of ischemic stroke with Rongshuan Tongmai Capsule combined with Buyang Huanwu Tang. Guangming J Chin Med 2021; 36 (21) 3573-3575
- 3 Zhang XL, Li Q. Efficacy of Buyang Huanwu Tang in the treatment of cerebral thrombosis. Shenzhen J Integr Tradit Chin-West Med 2022; 32 (01) 52-55
- 4 Chen XP. Clinical efficacy of Buyang Huanwu Tang in the treatment of cerebral thrombosis. China Med Guide 2021; 19 (28) 122-123
- 5 Wang FR, Wang W. Clinical observation of Buyang Huanwu Tang combined with Xueshuantong Injection in the treatment of acute ischemic stroke. Guangming J Chin Med 2023; 38 (14) 2795-2798
- 6 Luo QY. Observation on the efficacy of Angong Niuhuang Wan in the treatment of 32 cases of acute stroke. Chin J Ethnomed Ethnopharm 2009; 18 (10) 45-46
- 7 Zhang WJ, Huang Y. Overview of the current status of Angong Niuhuang Wan in the treatment of acute stroke. Zhongchengyao 2015; 37 (09) 2019-2022
- 8 Li HK, Guo HJ, Lyu X. et al. Recent research overview of Dahuoluo Wan. Chinese Archives of Traditional Chinese Medicine online. June 6, 2023
- 9 Huang XF. Study on the role of Dahuoluo Wan in the recovery of neurological function in patients with cerebral infarction. Clin J Tradit Chin Med 2014; 26 (07) 677-678
- 10 Zhu GS. Integrated traditional Chinese and Western medicine treatment for post-stroke sequelae. CCD 2006; 22 (14) 103-104 (Comprehensive Edition)
- 11 Yang HS, Han GX. Clinical efficacy observation of Dahuoluo Wan in preventing recurrence of cerebral infarction. Jilin J Tradit Chin Med 2022; 42 (03) 307-311
- 12 Guo J, Chen X, Wu M. et al.; CHAIN investigators. Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial. Lancet 2024; 404 (10468): 2187-2196
- 13 Maida CD, Norrito RL, Rizzica S, Mazzola M, Scarantino ER, Tuttolomondo A. Molecular pathogenesis of ischemic and hemorrhagic strokes: background and therapeutic approaches. Int J Mol Sci 2024; 25 (12) 6297
- 14 Mollet I, Marto JP, Mendonça M, Baptista MV, Vieira HLA. Remote but not distant: a review on experimental models and clinical trials in remote ischemic conditioning as potential therapy in ischemic stroke. Mol Neurobiol 2022; 59 (01) 294-325
- 15 Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22 (09) 391-397
- 16 Magid-Bernstein J, Girard R, Polster S. et al. Cerebral hemorrhage: pathophysiology, treatment, and future directions. Circ Res 2022; 130 (08) 1204-1229
- 17 Fu P, Zhang M, Wu M. et al. Research progress of endogenous hematoma absorption after intracerebral hemorrhage. Front Neurol 2023; 14: 1115726
- 18 Qin YJ, Liang ZJ. Cerebral infarction shortly after intracerebral hemorrhage. Adv Clin Med 2018; 8 (01) 53-58
- 19 Mracsko E, Veltkamp R. Neuroinflammation after intracerebral hemorrhage. Front Cell Neurosci 2014; 8: 388
- 20 Garg RK, Liebling SM, Maas MB, Nemeth AJ, Russell EJ, Naidech AM. Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. Stroke 2012; 43 (01) 67-71
- 21 Paulson OB, Waldemar G, Schmidt JF, Strandgaard S. Cerebral circulation under normal and pathologic conditions. Am J Cardiol 1989; 63 (06) 2C-5C
- 22 Bernick C, Kuller L, Dulberg C. et al.; Cardiovascular Health Study Collaborative Reseach Group. Silent MRI infarcts and the risk of future stroke: The Cardiovascular Health Study. Neurology 2001; 57 (07) 1222-1229
- 23 Bokura H, Kobayashi S, Yamaguchi S. et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 2006; 15 (02) 57-63
- 24 Zhang J, Yang Y, Sun H, Xing Y. Hemorrhagic transformation after cerebral infarction: current concepts and challenges. Ann Transl Med 2014; 2 (08) 81
- 25 Paciaroni M, Agnelli G, Corea F. et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008; 39 (08) 2249-2256
- 26 Wang J, Doré S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007; 27 (05) 894-908
- 27 Liesz A, Suri-Payer E, Veltkamp C. et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15 (02) 192-199
- 28 Malone K, Amu S, Moore AC, Waeber C. The immune system and stroke: from current targets to future therapy. Immunol Cell Biol 2019; 97 (01) 5-16
- 29 Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. Global brain inflammation in stroke. Lancet Neurol 2019; 18 (11) 1058-1066
- 30 Otsu Y, Namekawa M, Toriyabe M. et al. Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: A literature review. J Neurol Sci 2020; 419: 117217
- 31 Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke 2020; 22 (01) 29-46
- 32 Wu S. Integrative medicine for the treatment of stroke. Lancet 2024; 404 (10468): 2135-2137
- 33 Zheng GQ, Huang PX. Advances in the understanding of hemorrhagic stroke in traditional Chinese medicine. Chin J Med His 2005; 35 (01) 23-28
- 34 Tang RC. Theory of Blood Syndromes. Shanghai: Second Military Medical University Press; 2012: 135-137
- 35 Chen Y, Wang RC, Zhao EH. et al. Clinical application and research on the hemostatic effect of rhubarb. Shanghai J Tradit Chin Med 1987; 21 (09) 45-47
- 36 Liu J, Cai M, Le F. et al. Research progress on the treatment of cerebral hemorrhage with rhubarb. Chin J Integr Med Cardio-Cerebrovasc Dis 2017; 15 (22) 2837-2840
- 37 Wang JM, Wu WX. Experience in the application of rhubarb during the acute phase of cerebral hemorrhage. J Zhejiang Coll Tradit Chin Med 1980; (02) 17-18
- 38 Wang JG, Yuan HL, Qu JW. et al. Hemostatic effects and clinical applications of rhubarb. J Pharm Pract Serv 1994; (03) 44-46
- 39 Song CJ. “Ten prescriptions for rescue”and Dushen Tang (Single Ginseng Tang). Ginseng Res 2005; 17 (02) 2-3
- 40 Miao RY, Liu LL, Zhang XT. et al. Clinical verification of the usage, dosage, and efficacy of Dushen Tang (Single Ginseng Tang). Ginseng Res 2023; (04) 47-50
- 41 Hou W, Wang Y, Zheng P, Cui R. Effects of ginseng on neurological disorders. Front Cell Neurosci 2020; 14: 55
- 42 Li Y, Zhang TJ, Liu SX. et al. Research progress on chemical constituents and pharmacological effects of Panax ginseng. Chin Tradit Herb 2009; 40 (01) 164-166
- 43 Li Q, Chai YH, Gao J. et al. Research progress on modern pharmacological effects of Panax ginseng. J. Guiyang Univ Chin Med 2019; 41 (05) 89-92
- 44 Liu R, Li Y. Research progress on the effects of ginsenosides on the nervous and endocrine systems. Food Nutr Sci 2016; 5 (02) 31-36
- 45 Li AH, Ke KF, Wu XM. et al. Anti-ischemic effects and mechanisms of ginsenosides Rb1, Rb2, and Rg1 on cultured cortical neurons. J Apoplexy Nerv Dis 2004; 21 (03) 231-233
- 46 Liu A, Hu J, Yeh TS. et al. Neuroprotective strategies for stroke by natural products: advances and perspectives. Curr Neuropharmacol 2023; 21 (11) 2283-2309
- 47 Liu H, Li J, Xu W, Li Y, Yin L. Chinese herbal medicine Buyang Huanwu Decoction in treatment of peripheral nerve injury: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2023; 102 (29) e34256
- 48 Zhen Y, Shan X, Li YC. et al. Exploring the potential mechanism of Radix astragali against ischemic stroke based on network pharmacology and molecular docking. Phytomed Plus 2022; 2 (02) 100244
- 49 Jin G, Jin LL, Jin BX. The rationale behind the four major anti-coronavirus principles of Chinese herbal based on systems medicine. Acupunct Herb Med 2021; 1 (02) 90-98
- 50 Zhao W, Wu C, Dornbos III D. et al. Multiphase adjuvant neuroprotection: A novel paradigm for improving acute ischemic stroke outcomes. Brain Circ 2020; 6 (01) 11-18
- 51 Xiong XY, Liu L, Yang QW. Refocusing neuroprotection in cerebral reperfusion era: new challenges and strategies. Front Neurol 2018; 9: 249
- 52 Shu PP, Zhu PF, Yang XL. et al. Correlation between anticoagulant activity in vitro and saponin content of six Panax species. Chin Tradit Herb 2019; 50 (04) 918-924
- 53 Li CT, Wang HB, Jia CW. Study on anticoagulant activity of extracts from Panax ginseng, Panax quinquefolius, and Panax notoginseng. J Changchun Univ Chin Med 2011; 27 (02) 169-170
- 54 Wu L, Song H, Zhang C. et al. Efficacy and safety of Panax notoginseng saponins in the treatment of adults with ischemic stroke in China: a randomized clinical trial. JAMA Netw Open 2023; 6 (06) e2317574
- 55 Chen Y, Zhang Y, Wu Q, Chen J, Deng Y. The neuroprotective effect of Chinese herbal medicine for cerebral ischemia reperfusion injury through regulating mitophagy. Front Pharmacol 2024; 15: 1378358
- 56 Luan ZQ, Cao WF. Research progress on antioxidant and anti-aging effects of traditional Chinese medicine. Guangdong Medical 2011; 32 (05) 668-670
- 57 Liu X, Xu YZ, Liu JH. et al. Exploring the medication rules of traditional Chinese medicine combined with thrombolysis in the treatment of acute cerebral infarction based on data mining. Chin Med Herald 2024; 21 (27) 101-106
- 58 Huang S, Chen J, Liu X. et al. Evaluation of the pharmaceutical activities of Chuanxiong, a key medicinal material in traditional Chinese medicine. Pharmaceuticals (Basel) 2024; 17 (09) 1157
- 59 Wang HS, Zhao XD. Research overview on blood-activating and stasis-removing therapy in the acute phase of cerebral hemorrhage. J Integr Tradit-West Med 1990; 10 (11) 694-696
- 60 He S, He X, Pan S, Jiang W. Exploring the mechanism of Chuanxiong rhizoma against thrombosis based on network pharmacology, molecular docking and experimental verification. Molecules 2023; 28 (18) 6702
- 61 Han Y, Chen Y, Zhang Q. et al. Overview of therapeutic potentiality of Angelica sinensis for ischemic stroke. Phytomedicine 2021; 90: 153652
- 62 Li LJ, Shang DS, Du HM. et al. Clinical study on Safflor Yellow Injection in the treatment of acute cerebral infarction. J Beijing Univ Chin Med 2008; 15 (01) 1-4
- 63 Qi T, Peng JX, Liu XL. et al. Clinical study on Danhong Injection in the treatment of cerebral infarction patients. World J Tradit Chin Med 2015; 10 (04) 534-535
- 64 Wei JJ. Progress in integrated traditional Chinese and western medicine treatment for cerebral infarction. Tianjin Pharm 2016; 28 (04) 56-58
- 65 Wang HR. Why is panax notoginseng called the golden hemostatic herb?. People's Daily 2017; 02: 25
- 66 Ding CL, Wang YF, Wang HX. Clinical analysis of Tongxinluo in the treatment of 80 cases of cerebral infarction in the recovery period. Int J Clin Exp Med 2011; 10 (15) 1187-1188
- 67 Al-Shahi Salman R, Greenberg SM. Antiplatelet agent use after stroke due to intracerebral hemorrhage. Stroke 2023; 54 (12) 3173-3181
- 68 Yu JF, Wu XH, Hu C. et al. Recent research progress on antiplatelet aggregation mechanism of neutral blood-activating and stasis-removing traditional Chinese medicine and chemical components. Jiangxi Chem Ind 2023; 2: 6-9
- 69 Yu JF, Wu XH, Hu C. et al. Recent research progress on antiplatelet aggregation mechanism of cold and cooling blood-activating and stasis-removing traditional Chinese medicine and chemical components. Pract Clin J Int Tradit Chin-West Med 2022; 22 (20) 124-128
- 70 Yu JF, Hu C, Wu XH. et al. Antiplatelet aggregation mechanism of warming blood-activating and stasis-removing traditional Chinese medicine and its active components. J Tradit Chin Vet Med 2023; 42 (03) 34-40
- 71 Liu Y, Yin HJ, Shi DZ. et al. The use of Chinese medicinal herbs and formulas that activate blood circulation and antiplatelet therapies. Chin Sci Bull 2014; 59: 647-655
- 72 Li DY, Kong Y. Clinical research progress of traditional Chinese medicine in treating intracerebral hemorrhage. Zhong Yi Xue 2024; 13 (11) 3181-3185
- 73 Jiang N. Medication rules for treating acute cerebral hemorrhage with traditional Chinese medicine based on frequency analysis. Chin Med Sci 2021; 11 (20) 16-19
- 74 Yang HD, Yang YK. Exploring the medication rules of traditional Chinese medicine for acute cerebral hemorrhage based on data mining. Asia-Pacif Tradit Med 2023; 19 (01) 159-164
- 75 Yuan HW. Blood-activating and stasis-removing therapy in the early treatment of cerebral hemorrhage. Chin J Integr Trad-West Med Int-Crit Care 2006; 13 (06) 382-384
- 76 Wu K, Li B, Liu JF. et al. Clinical study on Huoxue Lishui Formula in treating acute cerebral hemorrhage with phlegm-stasis blocking collaterals syndrome. Chin J Integr Med on Cardio-Cerebrovascular D 2021; 19 (14) 2325-2328
- 77 Lin QW, Zeng QB, Song JC. Research progress on emodin in the treatment of sepsis-induced coagulation disorders. J Pract Shock 2018; 2 (05) 301-304
- 78 Nemmar A, Al Dhaheri R, Alamiri J. et al. Diesel exhaust particles induce impairment of vascular and cardiac homeostasis in mice: ameliorative effect of emodin. Cell Physiol Biochem 2015; 36 (04) 1517-1526
- 79 Li DH, Wu HW, Li GF. et al. Determination of total polyphenols and anthraquinones in rhubarb and study on the spectrum-effect relationship of its antioxidant activity in vitro. Nat Prod Res Dev 2022; 34 (04) 541-552
- 80 Guo DJ, Yang WT, Tian J. et al. Effects of Panax notoginseng on neural plasticity after cerebral ischemia-reperfusion injury. Chin J Rehab 2003; 18: 132-134
- 81 Pan HX, Chen ZM. Clinical observation of Xuesaitong Injection in the treatment of cerebral hemorrhage. Intl Med Health Guid News 2010; 16 (01) 59-60
- 82 Xue ZZ, Yao YQ, Zhang YX. et al. Pharmacological and clinical research progress of Chinese patent medicine and classical prescriptions in the treatment of cerebral edema. Drug Evaluation Research 2023; 46 (08) 1794-1801
- 83 Iee KR, Colon GP, Betz AL. et al. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 1996; 84 (01) 91-96
- 84 Wang JX, Luo HF. A new thrombolytic drug: hirudin. Chin Pharm Chem J 1993; 13: 321
- 85 Zhang HY, Yang XM, Yang YG. et al. Effect of Hirudo capsule on neurological function in patients with acute hemorrhagic stroke. Chin Trad Chin Med Inf J 2001; 8: 50-51
- 86 Tan J, Zhang JX, Wu XY. et al. Observation on the efficacy of high-dose ligustrazine in the treatment of acute hypertensive cerebral hemorrhage. Xinxiang Med College J 2002; 19 (02) 204-205
- 87 Lin W, Hou J, Han T, Zheng L, Liang H, Zhou X. Efficacy and safety of traditional Chinese medicine for intracranial hemorrhage by promoting blood circulation and removing blood stasis: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2022; 13: 942657
- 88 Li RK, Zhao H, Zhang YY. et al. Efficacy observation of Salvia miltiorrhiza injection in treating 15 cases of acute hypertensive cerebral hemorrhage. Chin J Integr Tradit-West Med Int-Crit Care 1999; 6: 462-465
- 89 Jha SK. Cerebral edema and its management. Med J Armed Forces India 2003; 59 (04) 326-331
- 90 Julian T, Hoff MD. Clinical and experimental studies on intracerebral hemorrhage. Chin J Nerv Ment Dis 1999; 25 (01) 1-4
- 91 Chang Q, Ma ZQ. Effect of Salvia miltiorrhiza combined with Xingnaojing Injection on secondary brain edema and activities of daily living in patients with hypertensive cerebral hemorrhage. Chin Foreign Med Res 2020; 39 (13) 93-95
- 92 Li JJ, Lv Z, Zhang P. Clinical study of Taohe Chengqi Tang combined with mannitol in the treatment of cerebral edema in the acute stage of hypertensive cerebral hemorrhage. Pract Geriatr 2018; 32 (09) 849-851
- 93 Pan MH, Chiou YS, Tsai ML, Ho CT. Anti-inflammatory activity of traditional Chinese medicinal herbs. J Tradit Complement Med 2011; 1 (01) 8-24
- 94 Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011; 13 (04) 289-301
- 95 Liu B, Yu T, Han XL. et al. Research progress on the anti-Inflammatory effects and molecular mechanisms of Ginsenosides. Chung Kuo Yao Hsueh Tsa Chih 2019; 54 (04) 253-258
- 96 Ren Y, Song CS, Liu XH, Shi Y, Gao JF, He XD. [Experimental study on compatible application of heat-clearing and detoxifying drugs with blood circulation improving drugs]. Zhongguo Zhongyao Zazhi 1994; 19 (10) 626-628 , 640
- 97 Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms, disease associations and management. Curr Pharm Des 2012; 18 (11) 1478-1493
- 98 Li XF, Yuan L. Research progress on inflammation and thrombosis. Foreign Med Sci Blood Transfus Hematol 2005; 28 (05) 417-420
- 99 Kohli S, Shahzad K, Jouppila A, Holthöfer H, Isermann B, Lassila R. Thrombosis and inflammation-a dynamic interplay and the role of glycosaminoglycans and activated protein C. Front Cardiovasc Med 2022; 9: 866751
- 100 Lü M, Wang TY, Tian XX. et al. [Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis]. Yao Xue Xue Bao 2015; 50 (09) 1135-1141
- 101 Sommeijer DW, MacGillavry MR, Meijers JC, Van Zanten AP, Reitsma PH, Ten Cate H. Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes. Diabetes Care 2004; 27 (02) 468-473
- 102 Levi M. The dual face of heparin in severe infection. Blood 2014; 123 (07) 947-948
- 103 Cheng F, Hu KM, Zhu S. Research progress on the anti-inflammatory mechanisms of traditional Chinese medicine for promoting blood circulation and removing blood stasis. Chin Med Herald 2023; 20 (08) 46-65
- 104 Zhao Y, Cui W, Xie T. et al.; for CHAIN investigators. Efficacy and safety of Chinese herbal medicine in patients with acute intracerebral hemorrhage: protocol for a randomized placebo-controlled double-blinded multicenter trial. Cerebrovasc Dis 2024; 53 (04) 501-508
- 105 Niu H. Author of the “lancet” Double-Blind Trial on Xingnao Liquid: Never Expected it to be Ineffective. China Newsweek 2024; 11: 23
- 106 Jin GT, Ling F, Bao YH. et al. Principles of systems medicine. Beijing: China Science and Technology Press; 2017: 55
- 107 National Health Commission of the People's Republic of China. Notice on the issuance of guidelines of diagnosis and treatment for 2019-nCoV infected pneumonia, 6th ed. 2020 . Accessed March 21, 2025 at: http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml?from=timeline
- 108 Kim CH, Kim JS. Development of cerebral infarction shortly after intracerebral hemorrhage. Eur Neurol 2007; 57 (03) 145-149
- 109 Zhang CL, Xiang D, Liu D. Modern research on calculus bovis (Part 1): Retrospect and prospect. Herald Med 2017; 36 (01) 1-8
- 110 Chen H, Luo Y, Tsoi B, Gu B, Qi S, Shen J. Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation. Chin Med 2022; 17 (01) 51
- 111 Tsoi B, Chen X, Gao C. et al. Neuroprotective effects and hepatorenal toxicity of Angong Niuhuang Wan against ischemia-reperfusion brain injury in rats. Front Pharmacol 2019; 10: 593
- 112 Tsoi B, Wang S, Gao C. et al. Realgar and cinnabar are essential components contributing to neuroprotection of Angong Niuhuang Wan with no hepatorenal toxicity in transient ischemic brain injury. Toxicol Appl Pharmacol 2019; 377: 114613
- 113 Wang QR. Yi lin gai cuo (corrections on errors in medical classics). Beijing: China Medical Science Press; 2016
- 114 Liu H, Yan Y, Pang P. et al. Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials. J Ethnopharmacol 2019; 237: 307-313
- 115 Yang A, Wu HM, Tang JL, Xu L, Yang M, Liu GJ. Acupuncture for stroke rehabilitation. Cochrane Database Syst Rev 2016; 2016 (08) CD004131
- 116 Wang JH, Wang NN, Yuan B. et al. [Anti-inflammation mechanism of electro-scalp acupuncture in treatment of ischemic stroke based on IL-12 mediated JAK/STAT signaling pathway]. Zhongguo Zhenjiu 2022; 42 (10) 1137-1144
- 117 Zhang Y, Tang YW, Peng YT, Yan Z, Zhou J, Yue ZH. Acupuncture, an effective treatment for post-stroke neurologic dysfunction. Brain Res Bull 2024; 215: 111035
- 118 Wang LN, Wu FY, Zhang T. Effects of Buyang Huanwu Tang on patients with acute cerebral infarction of Qi deficiency and blood stasis syndrome: efficacy and impact on hemodynamic parameters and blood viscosity. Chin Med Dev 2022; 19 (18) 49-52
- 119 Bao ZY, Hu QL, Zhuang SD. et al. Observation on the efficacy of modified Buyang Huanwu Tang in the treatment of acute cerebral thrombosis. Intl Med Health Guide 2021; 27 (14) 2160-2161
- 120 Lu Q. Clinical efficacy observation of Buyang Huanwu Tang in the treatment of sequelae of cerebral infarction. Changchun Univ Tradit Chin Med J 2011; 27 (03) 427-428
- 121 Han XW, Song Z. Clinical therapeutic effect analysis of Buyang Huanwu Tang on sequelae of cerebral infarction. Tradit Chin Med-West Med Integr Cardiovasc Dis Dig J 2017; 5 (09) 91-92
- 122 Hu XT. The effect and influence of Buyang Huanwu Tang combined with acupuncture in the treatment of patients with cerebral infarction hemiplegia. Clin Res 2024; 32 (08) 114-117
- 123 Jin GY, Xiang JJ, Jin LL. Contemporary Medical Acupuncture - A Systems Approach. Beijing: Springer-Verlag and Higher Education Press; 2007
- 124 Jin GY, Jin LL, Jin BX, Zheng J, He BJ, Li SJ. Neural control of cerebral blood flow: scientific basis of scalp acupuncture in treating brain diseases. Front Neurosci 2023; 17: 1210537
- 125 Liu Z, Guan L, Wang Y, Xie CL, Lin XM, Zheng GQ. History and mechanism for treatment of intracerebral hemorrhage with scalp acupuncture. Evid Based Complement Alternat Med 2012; 2012: 895032
- 126 Dong GR, Zhang X, Li D, Han RH. Research on scalp acupuncture for acute hypertensive cerebral hemorrhage. Chin Acupunct Moxibust 1994; 14: 13-15
- 127 Dong GR, Wang Z, Wu BZ. Discussion on the mechanism of immediate effect of head needling on acute encephalorrhagia. Chin Acupunct Moxibust 1996; 14: 26-28
- 128 Chen Z, Wang X, Du S. et al. A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer's disease based on the neuroinflammatory. Chin Med 2024; 19 (01) 35
- 129 Jin GY. The concept of anti-inflammatory acupuncture and its prospects for clinical application. Chin Archiv TCM 2024; 42 (08) 16-24
- 130 Xu D, Bu XD. Research progress on acupuncture combined with Buyang Huanwu Tang in the treatment of sequelae of cerebral infarction. Zhong Yi Xue 2024; 13 (11) 3097-3102
- 131 Xue NL. Clinical effect analysis of Buyang Huanwu Tang combined with acupuncture in the treatment of sequelae of cerebral infarction. Xitong Yixue 2021; 6 (17) 142-144
- 132 Tseng CY, Hsu PS, Lee CT. et al. Acupuncture and traditional Chinese herbal medicine integrated with conventional rehabilitation for post-stroke functional recovery: a retrospective cohort study. Front Neurosci 2022; 16: 851333
- 133 Mravec B. The role of the vagus nerve in stroke. Auton Neurosci 2010; 158 (1-2): 8-12
- 134 Srihagulang C, Vongsfak J, Vaniyapong T, Chattipakorn N, Chattipakorn SC. Potential roles of vagus nerve stimulation on traumatic brain injury: Evidence from in vivo and clinical studies. Exp Neurol 2022; 347: 113887
- 135 Bravo-Iñiguez CE, Fritz JR, Shukla S. et al. Vagus nerve stimulation primes platelets and reduces bleeding in hemophilia A male mice. Nat Commun 2023; 14 (01) 3122
- 136 Jin LL, Jin GY. Introduction to Jin's Auricular Reflex Zone System (JARZS). Int J Clin Acupunct 2018; 27 (03) 188-198